Primary Sclerosing Cholangitis in Children

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

December 30, 2021

Primary Completion Date

May 31, 2029

Study Completion Date

May 31, 2029

Conditions
Primary Sclerosing CholangitisLiver DiseasesCholangitis, Sclerosing
Trial Locations (12)

15224

RECRUITING

UPMC Children's Hospital of Pittsburgh, Pittsburgh

19104

RECRUITING

The Children's Hospital of Philadelphia, Philadelphia

30322

RECRUITING

Children's Healthcare of Atlanta, Atlanta

45229

RECRUITING

Cincinnati Children's Hospital Medical, Cincinnati

46202

COMPLETED

Riley Hospital for Children, Indianapolis

60611

RECRUITING

Ann & Robert H Lurie Children's Hospital, Chicago

77030

RECRUITING

Texas Children's Hospital (Baylor College of Medicine), Houston

80045

RECRUITING

Children's Hospital Colorado, Aurora

84113

RECRUITING

The University of Utah, Salt Lake City

90027

RECRUITING

Children's Hospital of Los Angeles, Los Angeles

98105

RECRUITING

Seattle Children's Hospital, Seattle

M5G 1X8

COMPLETED

The Hospital for Sick Children, Toronto

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Arbor Research Collaborative for Health

OTHER

NCT04181138 - Primary Sclerosing Cholangitis in Children | Biotech Hunter | Biotech Hunter